Warner Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35M Buy
1,124
+1
+0.1% +$1.02K 0.4% 50
2026
Q1
$1.03M Hold
1,123
0.35% 57
2025
Q4
$1.21M Hold
1,123
0.42% 47
2025
Q3
$857K Hold
1,123
0.32% 58
2025
Q2
$875K Hold
1,123
0.36% 51
2025
Q1
$927K Buy
1,123
+633
+129% +$527K 0.41% 50
2024
Q4
$378K Hold
490
0.16% 86
2024
Q3
$434K Hold
490
0.19% 84
2024
Q2
$444K Sell
490
-494
-50% -$395K 0.22% 76
2024
Q1
$766K Sell
984
-983
-50% -$700K 0.38% 53
2023
Q4
$1.15M Buy
+1,967
New +$1.15M 0.65% 35

Other funds holding LLY

Warner Financial's LLY Position: Q2 2026 in Review

Warner Financial increased its Eli Lilly (LLY) stake by 0.09% in Q2 2026, buying an estimated $1.02K and bringing the position to 1,124 shares worth $1.35M. The position accounts for 0.4% of the portfolio, ranked #50.

Warner Financial first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 2,259 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Warner Financial held 1,124 shares of Eli Lilly worth $1.35M as of Q2 2026.
  • Warner Financial bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.4% of Warner Financial's portfolio in Q2 2026, its #50 holding.
  • Warner Financial first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 2,259 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Warner Financial's 13F filing for Q2 2026, filed 9 Jul 2026.